Switching to Another Oral Anticoagulant and Drug Discontinuation Among Elderly Patients With Nonvalvular Atrial Fibrillation Treated With Different Direct Oral Anticoagulants

We compared the risks of switching to another oral anticoagulant (OAC) and discontinuation of direct oral anticoagulants (DOACs) among elderly patients with nonvalvular atrial fibrillation (NVAF) who were prescribed rivaroxaban or dabigatran versus apixaban. Patients (≥65 years of age) with NVAF pre...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Argitaratua izan da:Clin Appl Thromb Hemost
Egile Nagusiak: Baker, Christine L., Dhamane, Amol D., Rajpura, Jigar, Mardekian, Jack, Dina, Oluwaseyi, Russ, Cristina, Rosenblatt, Lisa, Lingohr-Smith, Melissa, Lin, Jay
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: SAGE Publications 2019
Gaiak:
Original Article
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC6829636/
https://ncbi.nlm.nih.gov/pubmed/31418293
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1177/1076029619870249
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak